KalVista Pharmaceuticals (NASDAQ: KALV) reported Q2 EPS of ($0.22), versus ($0.50) reported last year. Revenue for the quarter came in at $5.59 million, versus $1.13 million reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.